SCHEMBL31695352

SCHEMBL31695352

N#Cc1c(-c2ccc(O)c(C(=O)O)c2)cc(-c2ccc(F)cc2)[nH]c1=N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ DHFR P00374 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ USP2 O75604 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TTR P02766 1/20 0.49
▸ ALB P02768 1/20 0.49
▸ HMGB1 P09429 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ CXCL12 P48061 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ SLC22A6 Q4U2R8 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ IL4 P05112 1/20 0.41
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29335418 0.86 IL4 (0.54) KDM4EALDH1A1KMT2AMEN1IL4
SCHEMBL31695313 0.86 IL4 (0.54) KDM4EALDH1A1KMT2AMEN1IL4
SCHEMBL31695334 0.83 IL4 (0.43) KDM4EALDH1A1KMT2AMEN1IL4
SCHEMBL31695360 0.83 IL4 (0.43) KDM4EALDH1A1KMT2AMEN1IL4
SCHEMBL31695335 0.80 KDM4E (0.59) KDM4EALDH1A1KMT2AMEN1USP2
SCHEMBL23841138 0.80 ATM (0.57) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL23920029 0.78 PIM1 (0.47) KDM4EALDH1A1KMT2AMEN1GAA
SCHEMBL31695295 0.78 KDM4E (0.48) KDM4EALDH1A1KMT2AMEN1USP2
SCHEMBL31695346 0.77 ATM (0.51) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL31695345 0.76 ATM (0.50) KDM4EALDH1A1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 ACMSD 4402/4885KDM4E 551/4885ALDH1A1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback